<DOC>
	<DOCNO>NCT01011257</DOCNO>
	<brief_summary>The investigator test hypothesis aspirin clopidogrel take twice daily augment antiplatelet efficacy patient elevate platelet turnover ( measure proportion reticulate ( young ) platelet ) compare daily dosing .</brief_summary>
	<brief_title>Studying Efficacy Aspirin &amp; Clopidogrel Healthy Subjects With Stable Coronary Artery Disease .</brief_title>
	<detailed_description>1 . To study whether healthy subject increase platelet turnover , twice daily dose aspirin 81 mg effective inhibit platelet compare day aspirin 81 mg. 2 . To study whether patient stable coronary artery disease ( CAD ) increase platelet turnover , twice daily dose aspirin 81 mg effective inhibit platelet compare day aspirin 81 mg. 3 . To study whether healthy subject increase platelet turnover , twice daily dose aspirin 81 mg clopidogrel 75 mg effective inhibit platelet compare daily aspirin clopidogrel . 4 . To study whether patient stable coronary artery disease ( CAD ) , increased platelet turnover aspirin resistance , oral fatty acid ( docosahexaenoic acid ( DHA ) eicosapentanoic acid ( EPA ) , 4 gm/day ) supplementation increase efficacy aspirin modify platelet function compare day aspirin 81 mg .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Group A : Healthy subject age 1864 year evidence coronary artery disease major risk factor CAD include smoking , diabetes mellitus , hyperlipidemia , hypertension obesity . Group B : Patients know CAD aged 1864 year take aspirin 81 mg daily antiplatelet therapy . Patients stable condition least one month post myocardial infarction . Group C : Patients know stable CAD age 1864 year take aspirin 81 mg clopidogrel 75 mg daily . Patients stable condition least one month post myocardial infarction . Subjects exclude use NSAID 's within one week prior study , renal insufficiency , inflammatory disorder rheumatologic condition , autoimmune disorder , active infection , malignancy undergo chemotherapy . Other exclusion criterion include contraindication aspirin include active bleeding , hypersensitivity , thrombocytopenia ( platelet count &lt; 50,000 ) anemia ( hemoglobin &lt; 10.0 gm/dl ) . We also exclude patient unstable angina recent ( less month ) CABG PCTA .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>CAD</keyword>
</DOC>